Hourly refreshMon, Sep 14, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

7,213 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance · Healthcare

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

WAYNE, Pa., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to six new employees. The Compensation Committee of the Board of Directors of Avalo approved the grants of nonstatutory stock options to purchase an aggregate of 78,000 shares of common stock (the “Options”) as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Sep 4 · 20:05GlobeNewswire
Finance · Healthcare

Kaplan Fox Reminds Hims & Hers Health, Inc. (HIMS) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 2, 2026

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may...

Sep 4 · 20:05mlpr-newsfile
Finance · Healthcare

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on September 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 83,600 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 17,900 shares of Vor Bio’s common stock to 6 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).

Sep 4 · 20:05GlobeNewswire
Healthcare

In-Home Personal Training for Seniors Grows in Ontario as HomeStretch Active Living Marks One Year

HomeStretch Active Living expanded from B.C. into Ontario in August 2025 with one kinesiologist. One year later, eleven deliver in-home personal training for seniors. The post In-Home Personal Training for Seniors Grows in Ontario as HomeStretch Active Living Marks One Year first appeared on

Sep 4 · 19:19PRUnderground
Healthcare

W�rtsil� Lifecycle Agreement to ensure reliable response capability for Mercy Ships hospital vessels

Technology group W�rtsil� has signed a Lifecycle Agreement with charity organisation Mercy Ships International. The contract covers a 5-year renewal of an existing service agreement for the world's largest purpose-built civilian hospital ship, the Global Mercy™, and a 3-year service agreement for the organisation's latest newbuild vessel, the Africa Mercy II. Both ships are fitted with W�rtsil� engines. The order was booked by W�rtsil� in Q3 2026. - - Mercy Ships provides free medical c... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360063

Sep 4 · 19:08WebWire
Healthcare

Resonant Clinical Solutions adquiere Creapharm Bioservices

-Resonant Clinical Solutions amplía sus capacidades de terapias avanzadas y almacenamiento criogénico con la adquisición de Creapharm Bioservices La expansión de sus servicios especializados en Europa se basa en la oferta global de biobancos de Resonant para dar soporte a programas...

Sep 4 · 18:48PR Newswire
Healthcare

Resonant Clinical Solutions erweitert mit der Übernahme von Creapharm Bioservices seine Kapazitäten für innovative Therapien und kryogene Lagerung

Der Ausbau des Angebots an spezialisierten Dienstleistungen in Europa baut auf dem globalen Biorepository-Angebot von Resonant auf und dient der Unterstützung komplexer klinischer Programme, darunter Zell- und Gentherapien LEESBURG, Virginia, 4. September 2026 /PRNewswire/ -- Resonant...

Sep 4 · 18:47PR Newswire
Healthcare

Armor Health and the Stark County Sheriff's Office Partner in Launching PATH Program at Stark County Jail and Celebrate First Graduates

MIAMI, Sept. 4, 2026 /PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, has launched the Prevention, Accountability, Treatment & Healing (PATH) Program at the Stark County Jail in Canton, Ohio. Launched in July, the program offers a...

Sep 4 · 18:32PR Newswire
Healthcare

TUSK Practice Sales Releases Q3 2026 Behavioral Health Market Report

CHARLOTTE, N.C., Sept. 4, 2026 /PRNewswire/ -- TUSK Practice Sales ("TUSK"), the premier healthcare-focused M&A Advisor, released its Q3 2026 Behavioral Health Market Report. The report reviews transaction activity across the behavioral health industry from the first and second quarters...

Sep 4 · 18:03PR Newswire
Healthcare

Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP

MUMBAI, India and NAPLES, Fla., Sept. 4, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...

Sep 4 · 17:42PR Newswire
Healthcare

Arkansas Regulators Approve Arkansas Blue Cross and Blue Shield's Affiliation With Cambia Health Solutions

PORTLAND, Ore. & LITTLE ROCK, Ark., September 04, 2026--The Arkansas Insurance Department has approved the strategic affiliation between Arkansas Blue Cross and Blue Shield and Cambia Health Solutions.

Sep 4 · 17:30mlpr-businesswire
Finance · Healthcare

Class Action Lawsuit Filed: Fractyl Health, Inc. (GUTS) - Join by October ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 4, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..

Sep 4 · 17:27PR-Inside
← Prev123602Next →